Physician profile
Ming Zhong
NPI 1265792816
$1,637.05
in general payments reported to CMS, 2019-2025
17 companies · $410 in 2025
The $410 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $519 · 2020: $202 · 2021: $135 · 2022: $262 · 2023: $45.04 · 2024: $63.46 · 2025: $410.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $518.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $518.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $287.32 | 2021-2022 | |
| Medtronic Vascular, INC. | $219.11 | 2019 | |
| Endologix LLC | $150.00 | 2025 | Torus Stent Graft System, Endocross Device |
| Boston Scientific Corporation | $148.84 | 2019-2025 | General - Tachy |
| Biotronik INC. | $132.54 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $129.16 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $115.21 | 2022-2025 | Jardiance |
| Abbott Laboratories | $103.70 | 2019-2023 | Optis |
| Abiomed | $88.53 | 2022-2025 | |
| Amgen INC. | $74.48 | 2019-2020 | |
| Shockwave Medical, INC | $57.68 | 2025 | |
| Janssen Pharmaceuticals, INC | $42.18 | 2020 | |
| Chiesi USA, INC. | $26.39 | 2024 | Cleviprex, Kengreal |
| Edwards Lifesciences Corporation | $18.04 | 2025 | Sapien 3 Ultra Resilia |
| Cardiovascular Systems INC. | $16.74 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $15.72 | 2020 | |
| Novartis Pharmaceuticals Corporation | $11.41 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ming Zhong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.